Mäenpää H - Search Results

1

Serum VEGF levels in women with a benign breast tumor or breast cancer.

Salven P, Perhoniemi V, Tykkä H, Mäenpää H, Joensuu H. Salven P, et al. Among authors: maenpaa h. Breast Cancer Res Treat. 1999 Jan;53(2):161-6. doi: 10.1023/a:1006178517505. Breast Cancer Res Treat. 1999. PMID: 10326793

2

Interferon alpha-2a therapy in 18 hemangioblastomas.

Niemelä M, Mäenpää H, Salven P, Summanen P, Poussa K, Laatikainen L, Jääskeläinen J, Joensuu H. Niemelä M, et al. Among authors: maenpaa h. Clin Cancer Res. 2001 Mar;7(3):510-6. Clin Cancer Res. 2001. PMID: 11297241

3

Interferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinoma.

Hernberg M, Virkkunen P, Bono P, Ahtinen H, Mäenpää H, joensuu H. Hernberg M, et al. Among authors: maenpaa h. J Clin Oncol. 2003 Oct 15;21(20):3770-6. doi: 10.1200/JCO.2003.01.536. J Clin Oncol. 2003. PMID: 14551295 Clinical Trial.

4

Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma.

Mäenpää H, Ristamäki R, Virtamo J, Franssila K, Albanes D, Joensuu H. Mäenpää H, et al. Leuk Lymphoma. 2000 May;37(5-6):585-92. doi: 10.3109/10428190009058511. Leuk Lymphoma. 2000. PMID: 11042519

5

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

Puputti M, Tynninen O, Sihto H, Blom T, Mäenpää H, Isola J, Paetau A, Joensuu H, Nupponen NN. Puputti M, et al. Among authors: maenpaa h. Mol Cancer Res. 2006 Dec;4(12):927-34. doi: 10.1158/1541-7786.MCR-06-0085. Mol Cancer Res. 2006. PMID: 17189383

6

Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.

Mäenpää HO, Heikkonen J, Vaalavirta L, Tenhunen M, Joensuu H. Mäenpää HO, et al. PLoS One. 2008 Apr 2;3(4):e1885. doi: 10.1371/journal.pone.0001885. PLoS One. 2008. PMID: 18382668 Free PMC article. Clinical Trial.

7

Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors.

Villikka K, Kivistö KT, Mäenpää H, Joensuu H, Neuvonen PJ. Villikka K, et al. Among authors: maenpaa h. Clin Pharmacol Ther. 1999 Dec;66(6):589-93. doi: 10.1053/cp.1999.v66.103403001. Clin Pharmacol Ther. 1999. PMID: 10613614

8

Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up.

Ahtiainen V, Vaalavirta L, Tenhunen M, Joensuu H, Mäenpää H. Ahtiainen V, et al. Among authors: maenpaa h. Acta Oncol. 2020 Sep;59(9):1064-1071. doi: 10.1080/0284186X.2020.1785003. Epub 2020 Jun 30. Acta Oncol. 2020. PMID: 32603613 Clinical Trial.

9

Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.

Gylling H, Pyrhönen S, Mäntylä E, Mäenpää H, Kangas L, Miettinen TA. Gylling H, et al. Among authors: maenpaa h. J Clin Oncol. 1995 Dec;13(12):2900-5. doi: 10.1200/JCO.1995.13.12.2900. J Clin Oncol. 1995. PMID: 8523053 Clinical Trial.

10

Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients.

Siironen P, Louhimo J, Nordling S, Ristimäki A, Mäenpää H, Haapiainen R, Haglund C. Siironen P, et al. Among authors: maenpaa h. Tumour Biol. 2005 Mar-Apr;26(2):57-64. doi: 10.1159/000085586. Epub 2005 May 3. Tumour Biol. 2005. PMID: 15870511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters